BIOBAY NERVOPANE FORTE CAPLET
BIOBAY NERVOPANE FORTE CAPLET : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL25076088NC
- Type
- Health supplement
- Published status
- PRODUCT APPROVED
- Licence holder
- GALAXIS HEALTHCARE SDN BHD
- Manufacturer
- Esprit Care Sdn. Bhd.
- Registration period starting
- 2025-07-03
- Published validity end
- 2030-07-03
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- À vérifier
Benfotiamine is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-15021. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| ALPHA LIPOIC ACID | ALPHA LIPOIC ACID[300 mg,1030 mg] | Not identified |
| BENFOTIAMINE | BENFOTIAMINE[100 mg,1030 mg] | Not identified |
| ZINC BISGLYCINATE | ZINC BISGLYCINATE[75 mg,1030 mg] | Zinc |
| D-CALCIUM PANTOTHENATE | D-CALCIUM PANTOTHENATE[54.35 mg,1030 mg] | Acide pantothénique (vitamine B5) |
| INOSITOL | INOSITOL[50 mg,1030 mg] | Inositol |
| PYRIDOXINE HYDROCHLORIDE | PYRIDOXINE HYDROCHLORIDE[30.40 mg,1030 mg] | Vitamine B6 |
| Vitamin D3 (Cholecalciferol) | Vitamin D3 (Cholecalciferol)[10 mg,1030 mg] | Vitamine D |
| CHROMIUM POLYNICOTINATE | CHROMIUM POLYNICOTINATE[5 mg,1030 mg] | Acide nicotinique (vitamine B3) |
| METHYLCOBALAMIN | METHYLCOBALAMIN[0.5 mg,1030 mg] | Vitamine B12 |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- ALPHA LIPOIC ACID[300 mg,1030 mg],BENFOTIAMINE[100 mg,1030 mg],ZINC BISGLYCINATE[75 mg,1030 mg],D-CALCIUM PANTOTHENATE[54.35 mg,1030 mg],INOSITOL[50 mg,1030 mg],PYRIDOXINE HYDROCHLORIDE[30.40 mg,1030 mg],Vitamin D3 (Cholecalciferol)[10 mg,1030 mg],CHROMIUM POLYNICOTINATE[5 mg,1030 mg],METHYLCOBALAMIN[0.5 mg,1030 mg]
- Valid until
- 2030-07-03
- Registration date
- 2025-07-03
- Published description
- HEALTH SUPPLEMENT
- Licence holder
- GALAXIS HEALTHCARE SDN BHD
- Producer
- Esprit Care Sdn. Bhd.
- Published name
- BIOBAY NERVOPANE FORTE CAPLET
- Published reference
- 2025012417362N
- Registration number
- MAL25076088NC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL25076088NC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vitamin D3 (Cholecalciferol)
Read the warning, when it applies and the studies cited
VITAMIN D (>1,000 - 2,500 IU)
Route of administration: Oral
Cautions and warnings
Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Applies to products containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.